Tech Company Financing Transactions
AmacaThera Funding Round
On 11/4/2025, AmacaThera received $5 million in financing from Pacira Pharmaceuticals.
Transaction Overview
Company Name
Announced On
11/4/2025
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Pacira Pharmaceuticals (Jonathan Slonin)
Proceeds Purpose
This partnership allows us to accelerate AMT-143's development while demonstrating the strength, versatility, and commercial appeal of our technology to future partners.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
160 College St. 530
Toronto ON, M5S3E1
Canada
Toronto ON, M5S3E1
Canada
Phone
Website
Email Address
Overview
AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications. Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Cooke
Browse more venture capital transactions:
Prev: 11/4/2025: Downstream venture capital transaction
Next: 11/4/2025: Fit Collective venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs